share_log

Radient Announces Update on Trading Reinstatement

Radient Announces Update on Trading Reinstatement

Radient 宣佈有關恢復交易的最新情況
newsfile ·  2023/04/03 20:00

Edmonton, Alberta--(Newsfile Corp. - April 3, 2023) - Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) ("Radient" or the "Company") is pleased to announce that the Company has applied to the TSX Venture Exchange (the "TSXV") to reinstate trading of its common shares and is preparing responses to the TSXV's enquiries and compiling the requisite materials.

艾伯塔省埃德蒙頓--(新聞文件公司-2023 年 4 月 3 日)-光電科技股份有限公司(TSXV:RTI)(OTCQX:RDDTF)(」辐射「或」公司「)欣然宣布,該公司已申請到 TSX 創業交易所(」TSXV「) 恢復其普通股的交易,並正準備回應 TSXV 的查詢並編制必要的材料。

As previously announced on March 30, 2023, the Alberta Securities Commission granted Radient a revocation order respecting a failure-to-file cease trade order ("FFCTO") that has been in effect since March 7, 2023. The revocation order also evidences the decision of the Ontario Securities Commission. The issuance of the revocation order follows the filing by Radient of its interim financial statements for the nine-month period ended December 31, 2022, and the related Management's Discussion and Analysis and Certifications on March 22, 2023. On March 8, 2023, following the issuance of the FFCTO, the TSXV suspended trading of the Company's common shares.

正如之前在 2023 年 3 月 30 日宣布的那樣,艾伯塔省證券委員會授予 Radient 一項撤銷令,以遵守失敗歸檔的停止交易訂單(」FFCTO「) 自 2023 年 3 月 7 日起生效。撤銷令也證明了安大略省證券委員會的決定。撤銷令的發布是在 Radient 提交截至 2022 年 12 月 31 日止九個月期間的中期財務報表,以及相關管理層於 2023 年 3 月 22 日進行討論和分析和認證之後的發布。2023 年 3 月 8 日,台交所集團在發行後,本公司普通股暫停交易。

The Company would like to thank its shareholders and supporters for their patience at this time and confirms that it will endeavour to issue regular press releases to keep investors apprised of the situation, including of any anticipated trading resumption timeline.

本公司謹感謝其股東和支持者目前的耐心等待,並確認將努力定期發布新聞稿,以使投資者了解情況,包括任何預期的恢復交易時間表。

About Radient

關於輻射

Radient is a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. Please visit for more information.

Radient 是一家生產多樣化,新穎和高品質大麻提取物和包裝產品的商業製造商。Radient 開發特殊產品和成分,其中包含廣泛的大麻素和萜烯型材,同時滿足最高的質量和安全標準。Radient 專注於創新,在配方和技術方面具有專業知識,為大麻和健康領域提供獨特的解決方案。請訪問以獲取更多信息。

For more information, please contact:

欲了解更多信息,請聯繫:

Steven Splinter, CEO & Director
ir@radientinc.com
Ph: 780 465 1318

史蒂芬·斯普林特, 首席執行官兼董事
ir@radientinc.com
平均值:780 465 1318

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

TSX 風險交易所和其監管服務提供商(如 TSX 風險交易所政策中所定義的那樣)都不對此版本的充分性或準確性承擔責任。

To view the source version of this press release, please visit

如欲查看此新聞稿的來源版本,請瀏覽

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論